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Abstract: 
RATIONALE: Substances based on the N-(2-
methoxybenzyl)phenethylamine template (‘NBOMe’ derivatives) play an 
important role in medicinal research but some of these derivatives have 
also appeared as ‘research chemicals’ for recreational use which attracted 
attention worldwide. A major challenge associated with newly emerging 
substances includes the lack of analytical data and the ability to correctly 
identify positional isomers.  
 
METHODS: Six N-benzylphenethylamines based on the 2,5-dimethoxy-4-
iodophenethylamine structure (‘25I’) and twelve substituted N-benzyl-5-
methoxytryptamines (‘5MT’) have been prepared and extensively 
characterized. Techniques used for characterization were gas 
chromatography ion trap mass spectrometry in electron and chemical 
ionization mode, liquid chromatography diode array detection (DAD), 
infrared spectroscopy, electrospray high mass accuracy quadrupole time-
of-flight tandem mass spectrometry, and triple quadrupole tandem mass 
spectrometry.  
 
RESULTS: The characterization of eighteen ‘NBOMe’ analogs provided a 
comprehensive collection of chromatographic and spectral data. Four 
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groups of three positional isomers, i.e. 25I-NB2OMe, 25I-NB3OMe, 25I-
NB4OMe, 25I-NB2B, 25I-NB3B, 25I-NB4B and their 5-methoxytryptamine 
counterparts, were included and assessed for ability to differentiate 
between them. Six meta-substituted N-benzyl derivatives of 5-
methoxytryptamine (CF3, F, CH3, Cl, I, SCH3) were also studied.  
 
CONCLUSIONS: The implementation of mass spectral techniques was 
helpful for the differentiation between isomers, for example, when 
considering the difference in a number of ion ratios. This was considered 
beneficial in cases where chromatographic separation was only partially 
achieved under liquid chromatography (LC) conditions. The use of LC/DAD 
analysis was also found to be valuable for this particular purpose, which 
confirmed the integrative value of complementary techniques for areas 
related to forensic toxicology.  
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Abstract 
 
RATIONALE: Substances based on the N-(2-methoxybenzyl)phenethylamine 
template (‘NBOMe’ derivatives) play an important role in medicinal research but 
some of these derivatives have also appeared as ‘research chemicals’ for 
recreational use which attracted attention worldwide. A major challenge associated 
with newly emerging substances includes the lack of analytical data and the ability to 
correctly identify positional isomers.  
 
METHODS: Six N-benzylphenethylamines based on the 2,5-dimethoxy-4-
iodophenethylamine structure (‘25I’) and twelve substituted N-benzyl-5-
methoxytryptamines (‘5MT’) have been prepared and extensively characterized. 
Techniques used for characterization were gas chromatography ion trap mass 
spectrometry in electron and chemical ionization mode, liquid chromatography diode 
array detection (DAD), infrared spectroscopy, electrospray high mass accuracy 
quadrupole time-of-flight tandem mass spectrometry, and triple quadrupole tandem 
mass spectrometry.  
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RESULTS: The characterization of eighteen ‘NBOMe’ analogs provided a 
comprehensive collection of chromatographic and spectral data. Four groups of three 
positional isomers, i.e. 25I-NB2OMe, 25I-NB3OMe, 25I-NB4OMe, 25I-NB2B, 25I-
NB3B, 25I-NB4B and their 5-methoxytryptamine counterparts, were included and 
assessed for ability to differentiate between them. Six meta-substituted N-benzyl 
derivatives of 5-methoxytryptamine (CF3, F, CH3, Cl, I, SCH3) were also studied.  
 
CONCLUSIONS: The implementation of mass spectral techniques was helpful for 
the differentiation between isomers, for example, when considering the difference in 
a number of ion ratios. This was considered beneficial in cases where 
chromatographic separation was only partially achieved under liquid chromatography 
(LC) conditions. The use of LC/DAD analysis was also found to be valuable for this 
particular purpose, which confirmed the integrative value of complementary 
techniques for areas related to forensic toxicology.  
 
 
Introduction 
 
The diverse nature of serotonin (5-HT) receptor activation forms a fundamental basis 
of the functioning of biological systems including human physiology and regulation 
and modulation of psychological operation.[1] In humans, profound alterations in 
mood, thought, and cognition can be induced by a range of substances that activate 
the 5-HT2A receptor, which is believed to play a central role in the mediation of 
psychoactive effects associated with so-called ‘classic’ hallucinogens or 
psychedelics, such as lysergic acid diethylamide (d-LSD), psilocybin and a number of 
ring-substituted phenethylamines and amphetamines.[2-5] Although many of the highly 
selective 5-HT2A receptor agonists remain in the pre-clinical space, a diverse range 
of these derivatives has been encountered as commercially available ‘research 
chemicals’ used for recreational purposes.[6,7] 5-HT2A receptor agonist activity 
appears to be a necessary requirement for a compound to possess psychedelic 
effects although this might not always be sufficient.[8] It is this particular feature, 
however, that has led to the recreational and commercial exploration, including 
manufacturing and sale via various outlets, such as online retailers or ‘head shops’.  
 
The translation of laboratory-based research into a wider commodified open market 
has attracted concern worldwide. A number of N-(2-methoxybenzyl)phenethylamines 
became known as ‘NBOMe’ derivatives and common examples include 25I-NBOMe 
(1a) 25B-NBOMe and 25C-NBOMe (Figure 1A), although other substituted N-benzyl 
groups also have been encountered. Between 2011−2013, the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) received notifications from partners 
of the EU Early Warning System on the detection of 12 ‘NBOMe’ derivatives.[9-11] The 
United Nations Office on Drugs and Crime (UNODC) also confirmed the detection of 
‘NBOMe’ compounds in various UN Member States.[12] The World Health 
Organization, supported by the Expert Committee on Drug Dependence (ECDD), has 
recently held the 36th ECDD meeting to consider the available data on 25I-NBOMe 
(1a), 25B-NBOMe, and 25C-NBOMe for options regarding potential international 
control[13] and recommendations made are expected to be announced in due course. 
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In Europe, the Scientific Committee of the EMCDDA convened a risk assessment on 
25I-NBOMe,[14] which was later followed by a European Council decision to subject 
this substance to EU-wide control.[15] In the United States, 25I-NBOMe, 25B-NBOMe, 
and 25C-NBOMe have been temporarily scheduled into the Controlled Substances 
Act as Schedule 1 substances.[16] 
 
A common challenge associated with the ability to identify newly emerging 
psychoactive substances includes the lack of analytical data, which can reflect the 
fact that many of them may have only been described in the patent literature or 
medicinal and pharmacological literature, where comprehensive analytical 
characterization is often not carried out.[6] Once a particular analog of interest has 
been identified, further questions commonly arise when considering the presence of 
positional isomers, because reference standards for these isomers are often not 
available.  
 
The present study presents the analytical characterization of six N-
benzylphenethylamines (1a) – (1f) and twelve N-benzyl-5-methoxytryptamines (2a) – 
(3f) (Figure 1B). Four groups of three positional isomers that differed in the position 
of substituents on the N-benzyl group, e.g. 25I-NBOMe (1a) and its 3- and 4-
methoxybenzyl analogues (1b) and (1c), were included to determine the potential for 
differentiation using techniques commonly employed in forensic toxicology. The 
analytical characterizations were carried out by gas chromatography ion trap mass 
spectrometry in electron and chemical ionization mode, liquid chromatography diode 
array detection, infrared spectroscopy, electrospray high mass accuracy quadrupole 
time-of-flight tandem mass spectrometry and triple quadrupole tandem mass 
spectrometry.  
 
Experimental 
 
HPLC-grade acetonitrile was supplied by Rathburn Chemicals Ltd (Walkerburn, 
Scotland, UK) and triethylammonium phosphate (TEAP, 1.0 M) (pH 3.0) was 
obtained from Fluka (Gillingham, Dorset, UK). All other solvents and reagents were 
from Aldrich (Gillingham, Dorset, UK). All eighteen substituted N-benzyl derivatives 
(1a) – (3f) were synthesized following established procedures.[5,17,18] Syntheses and 
pharmacological data will be reported elsewhere.  
Gas chromatography ion trap mass spectrometry 
 
GC/MS data for all eighteen compounds (0.5 mg/mL in methanol) were obtained in 
electron (EI) and chemical ionization (CI) mode (scan range m/z 41 – m/z 500) using 
a Varian 450-GC gas chromatograph (Walnut Creek, CA, USA) coupled to a Varian 
220-MS ion trap mass spectrometer. A Varian 8400 autosampler was employed with 
a Varian CP-1177 injector (275 ºC) in split mode (1:50). Data acquisition was 
performed with the Varian MS Data Review function of the Workstation software, 
version 6.91. Transfer line, manifold and ion trap temperatures were set at 310, 80 
and 220 ºC, respectively. The carrier gas was helium at a flow rate of 1 mL/min using 
the EFC constant flow mode. The liquid CI reagent was HPLC grade methanol. The 
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default settings for CI ionization parameters (0.4 s/scan) were used: CI storage level 
m/z 19.0; ejection amplitude m/z 15.0; background mass m/z 55; maximum ionization 
time 2000 µs; maximum reaction time 40 ms; target TIC 5000 counts. A 30 m × 0.25 
mm (0.25 µm film thickness) Agilent J&W VF-5ms GC column (Agilent, Cheadle, UK) 
was employed for separation. The starting temperature was set at 130 ºC and held 
for 1 min. The temperature then increased at 20 ºC/min to 280 ºC and held constant 
for 11.50 min to give a total run time of 20.00 min. 
Electrospray triple quadrupole mass spectrometry 
 
Electrospray triple quadrupole tandem mass spectrometry experiments were carried 
out by direct infusion (10 μL/min at 0.01 mg/mL) of compounds using a Waters 
Micromass Quattro Premier triple quadrupole MS/MS system (Waters Micromass, 
Wythenshawe, Manchester, UK) operated under Masslynx v.4.1 software. MS 
optimizations were performed in MS scan and in product ion scan. Product ion scans 
were obtained in positive ion mode and optimized source condition settings were as 
follows: capillary 3.12 kV, cone 28 V, rf lens 0.1 V, source temperature 100 °C, 
desolvation temperature 200 °C and the multiplier voltage was 650 V. Nitrogen was 
used as the cone gas (50 L/h) and desolvation gas (200 L/h) whilst the collision gas 
was argon (0.3 mL/min flow). The [M + H]+ ion corresponding to all 18 substances 
were selected for MS/MS experiments. Product ions were collected over the range 
m/z 45 and m/z 500. Scan time for each channel was 0.5 s and interscan delay was 
0.1 s. The cone voltage was set at 28 V in all cases. The collision energy used for 
(1d) – (1f) was 10 eV while a value of 20 eV was chosen for the tryptamine based 
compounds (2a) – (3f), respectively. 
 
High-resolution electrospray mass spectrometry  
Analyses were carried out by characterization using UHPLC-QTOF-MS/MS as 
described previously.[19,20] Briefly, mobile phases used for UHPLC separation 
consisted of 100% acetonitrile (1% formic acid) and an aqueous solution of 1% 
formic acid. The column temperature was set at 40 °C (0.6 mL/min) and data were 
acquired for 5.5 min. The elution was a 5–70% acetonitrile gradient ramp over 3.5 
min, then increased to 95% acetonitrile in 1 min and held for 0.5 min before returning 
to 5% acetonitrile in 0.5 min. QTOF-MS data were acquired in positive mode 
scanning from m/z 100 – m/z 1000 with and without auto MS/MS fragmentation. 
Ionization was achieved with an Agilent JetStream electrospray source and infused 
internal reference masses. Agilent 6540 QTOF-MS parameters: gas temperature 325 
°C, drying gas 10 L/min and sheath gas temperature 400 °C. Internal reference ions 
at m/z 121.05087 and m/z 922.00979 were used.   
 
High performance liquid chromatography diode array detection 
HPLC-DAD analyses[19,20] were carried out on a Dionex 3000 Ultimate system 
coupled to a UV diode array detector (Thermo Fisher, St Albans, UK), using a 
Phenomenex Synergi Fusion column (150 mm x 2 mm, 4 µm) that was protected by 
a 4 mm x 3 mm Phenomenex Synergi Fusion guard column (Phenomenex, 
Macclesfield, UK). The mobile phases were made from 70% acetonitrile with 25 mM 
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TEAP buffer and an aqueous solution of 25 mM TEAP buffer. Elution was achieved 
with a gradient that started with 4% acetonitrile and ramped to 70% acetonitrile in 15 
min and held for 3 min. The total acquisition time was 18 min at a flow rate of 0.6 
mL/min. The diode array detection window was set at 200 nm to 595 nm (collection 
rate 2 Hz).  
Results and discussion 
 
The high potency associated with substances such as 25I-NBOMe (1a)[21,22] and the 
possibility that some of these 5-HT2A receptor agonists may not be orally active,
[23] 
might reflect the fact that these substances are often encountered in the form of 
absorbent paper (blotters), which are ingested via sublingual and buccal routes. 
However, the presence of powdered forms, capsules and liquids has also been 
reported.[14] Although the availability of bulk drugs may be amenable to a large range 
of analytical investigations, detection and identification in biofluids often requires the 
implementation of mass spectrometry based techniques due to the high potency 
associated with some of these derivatives.[24] Whilst knowledge about the formation 
of fragment and product ions form an important basis for the development of suitable 
screening techniques, further complexities might arise from the need to differentiate 
between isomers.[19] 
In addition to the study of bioactive N-benzylphenethylamines, a number of their 5-
methoxytryptamine counterparts were investigated. For example, in the rat tail artery 
assay, N-(2-methoxybenzyl)-5-methoxytryptamine (2a) has also been shown to have 
appreciable partial 5-HT2A receptor agonist activity (pEC50 = 7.08; Emax = 54% relative 
to serotonin),[25] which indicated potential for further exploration. Indeed, all of the 
characterized substituted N-benzylphenethylamines and 5-methoxytryptamines (1a) 
– (3f) (Figure 1B) characterized in the present study have recently undergone a 
comprehensive investigation into serotonin receptor affinity, functional activity and 
mouse head-twitch response in order to acquire insights into their structure-activity 
relationships and the results will be reported in due course. One of the observations 
made, and which will be reported in due course, was that meta-substitution in the N-
benzyl derivatives of 5-methoxytryptamine were important for their affinity to the 5-
HT2 receptor family and functional activity in vitro and in vivo.   
In the interest of clarity and brevity, a more detailed discussion of analytical data 
obtained for N-(methoxybenzyl)phenethylamine isomers (1a) – (1c) and N-
(methoxybenzyl)-5-methoxytryptamine isomers (2a) – (2c) is included in this 
manuscript to serve as representative examples. The data for all remaining 
derivatives, including infrared spectroscopy of all eighteen substances, are shown as 
supplementary information.  
Gas chromatography electron and chemical ionization ion trap mass spectrometry 
 
Gas chromatography (GC) retention times and ion trap (IT) electron- and chemical 
ionization (EI/CI) mass spectra for N-(methoxybenzyl)phenethylamine (1a) – (1c) are 
shown in Figure 2A−C as representative examples while the remaining mass spectra 
including all GC chromatograms are available as supplementary information. All 
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three sets of positional isomers, i.e. (1a) – (1f) and (2a) – (2f), could be separated 
under GC conditions and the elution order followed a similar pattern with increasing 
retention times in the order of ortho-, meta- and para-substitution which also was 
observed with a range of other isomeric N-(methoxybenzyl)phenethylamine 
analogs.[26] The EI-IT mass spectra obtained for the three 25I-NBOMe isomers (1a) – 
(1f) were largely consistent with the EI mass spectra reported previously using a 
quadrupole mass analyzer and included key fragments at m/z 121 (methoxylated 
tropylium ion) and m/z 150 (iminium ion formation following α-cleavage).[26] 
Correspondingly, the mass spectra associated with the three N-(bromobenzyl) 
substituted phenethylamine isomers (1d) – (1f) show the tropylium and iminium 
counterparts at m/z 169/171 and m/z 198/200, respectively (supplementary data). In 
contrast to N-(methoxybenzyl) isomers (1a) – (1c) that gave the same base peak at 
m/z 121, the brominated counterparts (1d) – (1f) revealed increasing relative 
abundance values for the equivalents at m/z 169/171 following the order of ortho- 
(1d), meta- (1e), and para-substitution (1f), respectively (supplemental data). 
Suggested EI-MS key fragments are shown in Figure 3A, which included suggestions 
incorporated from Zuba and colleagues on structurally related substances.[27-29] 
Representative GC-CI-IT-MS for N-(methoxybenzyl)phenethylamine analogs (1a) – 
(1c) are depicted in Figure 2D−F and revealed facile detection of the [M + H]+ ion at 
m/z 428 to confirm the mass of the molecule, which was more challenging under EI-
IT-MS conditions due to extensive fragmentation of the molecular ion. Some 
variations in the relative abundance of key fragments, e.g. m/z 91, m/z 121 and m/z 
150, have been reported previously for (1a) – (1c) when using a single quadrupole 
mass analyzer.[26] Similar variations have been observed in the present study under 
three-dimensional ion trap conditions (Figure 2A–C), which might point towards the 
ability to differentiate between isomers. A more pronounced difference that might 
allow for differentiation between the N-(methoxybenzyl)phenethylamine isomers on 
mass spectral grounds was observed under CI-IT-MS conditions (Figure 2D–F) when 
inspecting the relative abundance values for the m/z 121 ion. In the case of 25I-
NB4OMe (1c), this species formed the base peak whereas it was absent in the mass 
spectrum of the N-(3-methoxybenzyl) analog (1b). By contrast, 25I-NB2OMe (1a) 
yielded a relative abundance value of 20% for m/z 121. Interestingly, in the case of 
the three N-(bromobenzyl) isomers (1d) – (1f) the stability of the [M + H]+ ion at m/z 
476/478 dominated throughout the three CI mass spectra with negligible abundance 
values for the brominated tropylium counterpart at m/z 169/171 (supplemental data).  
GC retention times and EI/CI IT-MS data for N-(methoxybenzyl)-5-
methoxytryptamine isomers (2a) – (2c) are provided in Figure 2G–L. Similar to the 
corresponding phenethylamine 25I-NB4OMe (1c) (Figure 2C), the relative 
abundance of the m/z 150 iminium ion appeared to be significantly lower in the 
tryptamine counterpart (2c) (Figure 2I) when compared with the increased 
abundance observed in the EI-IT-MS of the remaining isomers. The tropylium ion at 
m/z 121 also formed the base peak in all three isomeric cases, similar to the 
phenethylamines (1a) – (1c). The main difference found in the EI-IT mass spectra, 
however, which facilitated the identification of the 5-methoxytryptamine moieties, was 
seen in key ions at m/z 160, m/z 145 and m/z 117. In addition, the key indicator that 
differentiated between a potentially existing N,N-dialkyltryptamine from a N-mono 
substituted compound, as is the case with the N-benzyl species, was the occurrence 
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of a strong m/z 161 ion which, for example, would not be observed with N,N-
dialkylated compounds (Figure 2G–I and 3B).[30] Interestingly, apart from 5MT-
NB3Me (3c), which yielded the methyltropylium base peak at m/z 105, all remaining 
N-benzyltryptamines (2d) – (2f), (3a), (3b) and (3d) – (3f), formed the base peak at 
m/z 161 (supplementary information). The CI-IT-MS data for N-benzyltryptamines 
(2a) – (2c) (Figure 2J–L) provided confirmation of the [M + H]+ ion as expected 
although, as observed with the phenethylamines, distinct differences where observed 
due to collision-induced dissociation, which might be useful for the ability to obtain 
differential mass spectra from these three isomers.  
Some moderate differences were noted in the abundance values associated with the 
N-(methoxybenzyl) group, i.e. m/z 121 and m/z 150. One feature that did not appear 
to be detected in the CI mass spectra of N-(methoxybenzyl)phenethylamine 
counterparts (1a) – (1c) (Figure 2D–F) was the appearance of an ion at m/z 294 that 
indicated a potential loss of ammonia from [M + H]+ (Figure 2J–L). As shown below, 
a similar loss of ammonia was observed under electrospray (ESI) tandem mass 
spectrometry conditions. It also appeared that the m/z 174 ion (also described below 
under ESI conditions), which has only been detected to a minor extent in N,N-
dialkylated tryptamines,[31] showed a comparatively higher abundance that differed 
between isomers (2a) – (2c) under CI conditions. Another ion of interest was at m/z 
162 (Figure 2 and supplementary data), which may be characteristic for N-
monosubstituted tryptamines when using GC-CI-IT-MS, i.e. absent in N,N-
dialkyltryptamines.[30,31]  
Electrospray ionization mass spectrometry 
 
All N-benzyl substituted phenethylamines (1a) – (1f), and 5-methoxytryptamines (2a) 
– (2f) and (3a) – (3f) were characterized by electrospray (ESI) high mass accuracy 
quadrupole time-of-flight tandem mass spectrometry (QTOF-MS/MS) and ESI triple 
quadrupole (QqQ) tandem mass spectrometry. The mass spectral data for N-
(methoxybenzyl) isomers (1a) – (1c) are presented in Figure 4. A comparison 
between QTOF-MS/MS (Figure 4A–C) and QqQ-MS/MS (Figure 4D–F) data showed 
an essentially similar trend with regards to the extent of product ion formation. The 
most extensive dissociation of the [M + H]+ ion to yield the largest number of product 
ions was observed in the spectra of 25-NB3OMe (1b), whereas 25I-NB4OMe (1c) 
appeared to give the lowest level of product ion diversity. Figure 4D–F also shows a 
summary of the ion ratios determined under QqQ-MS/MS conditions, which 
displayed the extent of differential dissociation. All three isomers gave the expected 
m/z 121 ion as a base peak. A selection of proposed structural representations of 
product ions that might have formed during MS/MS analysis is shown in Figure 5A, 
which were in part adapted from previously published work on related substances.[27-
29] Figure 5A also lists the calculated exact masses, whereas Table 1 lists the 
masses and suggested elemental formulae that could be detected by QTOF-MS/MS 
analysis with acceptable mass accuracy. In some cases, however, the product ion 
counts observed under QTOF-MS/MS conditions did not yield sufficient signal 
intensity to confirm the suggested elemental composition with acceptable accuracy 
although some species were more abundant when employing QqQ-MS/MS 
detection.  
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The ESI MS/MS data for N-(methoxybenzyl)tryptamines (2a) – (2c) can be seen in 
Figure 6 and the mass spectral information of the remaining twelve substances have 
been added as supplemental data. As observed with the phenethylamine 
counterparts, the relative abundance values observed with QTOF-MS/MS and QqQ-
MS/MS showed marked differences, which translated into distinct ion ratios (e.g. 
Figure 6D–F). Interestingly, the m/z 121 product ion formed the base peak in two 
rather than all three isomers. 5MT-NB3OMe (2b) produced a base peak at m/z 174. 
Visual inspection of both QTOF and QqQ spectra indicated comparable relative 
abundance values with regards to some of the ion ratios encountered. For example, 
the distinct ratios observed for the m/z 121 and m/z 174 species (e.g. Figure 6D–F), 
might serve as a helpful feature when dealing with these isomers in the absence of 
reference material. A summary of suggested product ions, in part adapted from 
previously published work on N,N-dialkylated tryptamines[30] is shown in Figure 5B 
and Table 2.  
 
The UHPLC-QTOF/MS method did not result in sufficient separation of the N-
(methoxybenzyl) isomers (1a) – (1c) and (2a) – (2c), which led to an implementation 
of an HPLC-DAD method that has been successfully applied previously as a 
screening method in forensic casework.[19,20,32,33] Figure 7 shows the retention times 
and overlaid DAD spectra following separation by HPLC. Both 25I-NB2OMe (1a) and 
5MT-NB2OMe (2a) were separated from the remaining two NB3OMe and NB4OMe 
isomers. Although NB3OMe and NB4OMe isomers (1b)/(1c) and (2b)/(2c) could not 
be separated, it was found that they could be distinguished by their full scan UV 
spectra (Figure 7A).  N-(methoxybenzyl)phenethylamines (1a) – (1c) showed a slight 
shift of increasing wavelengths with regards to the secondary UV maximum. The 
difference was especially pronounced in the case of the two co-eluting isomers (1b) 
(283.5 nm) and (1c) (298.3 nm). In addition, 25I-NB4OMe (1c) displayed a distinct 
shoulder at 226.1 nm that was absent in the ortho- and meta- NBOMe isomers (1a) 
and (1b). Whilst some of the spectral differences were seemingly small, experiences 
in casework has previously shown how valuable these can be when dealing with 
isomers and other closely related compounds.[19,20] Similarly, although the 5MT-
based N-(methoxybenzyl) isomer (2a) could be separated from the meta- and para-
substituted isomers (2b) and (2c), inspection of their UV full scan spectra confirmed 
the presence of distinctive differences to facilitate their differentiation (Figure 7B). By 
contrast, all three 5MT-based N-(bromobenzyl) isomers (2d) – (2f) were fully 
separated under identical conditions (supplemental information). 
 
 
Conclusion 
 
As is the case with most new psychoactive substances, the appearance of potent 5-
HT2 receptor agonists on the ‘research chemicals’ market highlighted the need to 
provide analytical data. The present study undertook a comprehensive analytical 
characterization of six N-benzylphenethylamines and twelve N-benzyl-5-
methoxytryptamines and the majority of these substances have not yet been 
described in the analytical literature. Differentiation between positional isomers may 
be obtained by mass spectral investigations to some extent but the implementation of 
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chromatographic techniques with additional methods such as diode array detection 
were found to offer additional value. The collection of spectral data provided in the 
present study was aimed to support those researchers in the field who have to deal 
with exposure to these particular substances, such as clinicians, forensic providers 
and law enforcement.  
 
 
 
Figure captions 
 
Figure 1. A: Three representative 5-HT2A receptor agonists and N-
benzylphenethylamine derivatives 25I- (1a), 25B-, and 25C-NBOMe that are 
available as recreational psychoactive substances. B: chemical structures of 
‘NBOMe’ derivatives (1a) – (3f) subjected to analytical characterization. 
 
Figure 2. Gas chromatography retention times, electron (EI)- and chemical (CI) 
ionization ion trap (IT) mass spectra of N-(methoxybenzyl) substituted isomers (1a) – 
(1c) and (2a) – (2c). 
 
Figure 3. Structural representations of suggested key ions formed during analysis by 
electron ionization ion trap mass spectrometry. A: 25I-NBOMes (1a) – (1f). B: 5-MT-
NBOMes (2a) – (3f).  
 
Figure 4. Electrospray ionization mass spectra obtained from positional 25I-NBOMe 
isomers (1a) – (1c). A – C: UHPLC-QTOF-MS/MS. The retention time of (1c) in trace 
C, i.e. associated with the peak top was 2.66 min. The given retention time of 2.82 
min represented the attempt to obtain a less saturated signal response for the base 
peak ion. D – F: direct infusion triple quadrupole MS/MS and corresponding ion 
ratios.  
 
Figure 5. Structural representations of suggested key ions formed during analysis by 
QTOF-MS/MS and their calculated theoretical m/z values. A: 25I-NBOMes (1a) – 
(1c). B: 5-MT-NBOMes (2a) – (2c).  
 
Figure 6. Electrospray ionization mass spectra obtained from positional 5-MT-
NBOMe isomers (2a) – (2c). A – C: UHPLC-QTOF-MS/MS. D – F: direct infusion 
triple quadrupole MS/MS and corresponding ion ratios.  
 
Figure 7. HPLC retention times and full scan UV spectra (DAD) for the N-
(methoxybenzyl) substituted isomers. A: (1a) – (1c) and B: (2a) – (2c). Differentiation 
was possible by the combination of UV full scan and retention time data.  
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Figure 1. A: Three representative 5-HT2A receptor agonists and N-benzylphenethylamine derivatives 25I- 
(1a), 25B-, and 25C-NBOMe that are available as recreational psychoactive substances. B: chemical 
structures of ‘NBOMe’ derivatives (1a) – (3f) subjected to analytical characterization.  
243x874mm (300 x 300 DPI)  
 
 
Page 14 of 21
http://mc.manuscriptcentral.com/rcm
Rapid Communications in Mass Spectrometry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 2. Gas chromatography retention times, electron (EI)- and chemical (CI) ionization ion trap (IT) mass 
spectra of N-(methoxybenzyl) substituted isomers (1a) – (1c) and (2a) – (2c).  
194x175mm (300 x 300 DPI)  
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Figure 3. Structural representations of suggested key ions formed during analysis by electron ionization ion 
trap mass spectrometry. A: 25I-NBOMes (1a) – (1f). B: 5-MT-NBOMes (2a) – (3f).  
245x336mm (300 x 300 DPI)  
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Figure 4. Electrospray ionization mass spectra obtained from positional 25I-NBOMe isomers (1a) – (1c). A – 
C: UHPLC-QTOF-MS/MS. The retention time of (1c) in trace C, i.e. associated with the peak top was 2.66 
min. The given retention time of 2.82 min represented the attempt to obtain a less saturated signal 
response for the base peak ion. D – F: direct infusion triple quadrupole MS/MS and corresponding ion ratios. 
268x350mm (300 x 300 DPI)  
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Figure 5. Structural representations of suggested key ions formed during analysis by QTOF-MS/MS and their 
calculated theoretical mass values. A: 25I-NBOMes (1a) – (1c). B: 5-MT-NBOMes (2a) – (2c).  
270x351mm (300 x 300 DPI)  
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Figure 6. Electrospray ionization mass spectra obtained from positional 5-MT-NBOMe isomers (2a) – (2c). A 
– C: UHPLC-QTOF-MS/MS. D – F: direct infusion triple quadrupole MS/MS and corresponding ion ratios.  
257x316mm (300 x 300 DPI)  
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Table 1. Product ions obtained from N-(methoxybenzyl) substituted phenethylamines (1a) – (1c). 
Suggested elemental formulae of proposed product ions (Figure 5A) that could be detected by 
QTOF-MS/MS analysis with acceptable mass accuracy. 
Compound Measured m/z 
value 
Suggested 
formula 
Calculated m/z 
value 
∆m 
[ppm] 
(1a) 25I-NB2OMe 428.07239 (PM) C18H23INO3
+
 428.07171 - 1.59 
 314.08502 No formula 314.08  
 290.98702 C10H12IO2
+
 290.98765 + 2.17 
 179.01278 C12H13O2
●+
 179.01276 - 0.11 
 134.07023 C9H10O
●+
 134.07262 - 17.8 
 121.06435 (BP) C8H9O
+
 121.06479 + 3.68 
 106.04068 C7H6O
●+
 106.04068 - 6.04 
 91.05359 C7H7
+
 91.05423 + 7.07 
     
(1b) 25I-NB3OMe 428.07319 (PM) C18H23INO3
+
 428.07171 - 3.46 
 306.99932 C10H13INO2
+
 305.99855 - 2.53 
 290.98870 C10H12IO2
+
 290.98765 - 3.62 
 275.96503 C9H9IO2
●+
 275.96417 + 3.12 
 179.09422 C10H13NO2
●+
 179.09408 + 0.78 
 164.08342 C10H12O2
●+
 164.08318  + 1.46 
 149.05990 C9H9O2
+
 149.05971 - 1.31 
 134.07320 C9H10O
●+
 134.07262 + 4.33 
 121.06552 (BP) C8H9O
+
 121.06479 - 6.07 
 91.05488 C7H7
+
 91.05423 - 6.26 
 65.03911 C5H5
+
 65.03858 - 8.33 
     
(1c) 25I-NB4OMe 428.07302 (PM) C18H23INO3
+
 428.07171  
 121.06520 (BP) C8H9O
+
 121.06479 - 3.40 
 106.04158 C7H6O
●+
 106.04132  + 2.45 
 91.05437 C7H7 
+
 91.05423 - 1.59 
 77.03923 C6H5
+
 77.03858 - 8.59 
PM: [M + H]
+
 ion; BP: base peak. 
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Table 2. Product ions obtained from N-(methoxybenzyl) substituted 5-methoxytryptamines (2a) – 
(2c). Suggested elemental formulae of proposed product ions (Figure 5B) that could be detected 
by QTOF-MS/MS analysis with acceptable mass accuracy. 
Compound Measured m/z 
value 
Suggested 
formula 
Calculated m/z 
value 
∆m 
[ppm] 
(2a) 5MT-NB2OMe 311.17548 (PM) C19H23N2O2
+
 311.17540 - 0.24 
 294.14793 C19H20NO2
+
 294.14886 + 3.16 
 262.11985 C18H16NO
+
 261.11536 + 10.69 
 203.11684 C12H15N2O
+
 203.11789 + 5.19 
 186.09101 C12H12NO
+
 186.09134 + 1.79 
 174.09042 (BP) C11H12NO
+
 174.09134 + 5.32 
 162.09067 C10H12NO
+
 162.09134 + 4.16 
 121.06468 C8H9O
+
 121.06479 + 0.93 
 103.05381 C8H7
+
 103.05423 + 4.08 
 91.05407 C7H7
+
 91.05423 + 1.74 
 65.03869 C5H5
+
 65.03858 - 1.77 
     
(2b) 5MT-NB3OMe 311.17650 (PM) C19H23N2O2
+
 311.17540 - 3.53 
 294.14838 C19H20NO2
+
 294.14886 + 1.62 
 174.09190 (BP) C11H12NO
+
 174.09134 - 3.23 
 162.09136 C10H12NO
+
; 162.09134 - 1.8 
 150.09104 C9H12NO
+
 150.09134 + 2.02 
 131.07282 C9H9N
●+
 131.0735 - 5.19 
 121.06507 (BP) C8H9O
+
 121.06479 - 2.32 
 91.05434 C7H7
+
 91.05423 - 1.26 
 65.03869 C5H5
+
 65.03858 - 1.77 
 77.03878 C6H5
+
 77.03858 - 2.68 
     
(2c) 5MT-NB4OMe 311.17632 (PM) C19H23N2O2
+
 311.17540 - 2.95 
 294.15033 C19H20NO2
+
;  294.14886 - 5.03 
 174.09207 C11H12NO
+
 174.09134 - 4.22 
 160.07655 C10H10NO
+
 160.07569 - 5.40 
 147.08066 C10H11O
+
 147.08044 - 1.50 
 121.06565 (BP) C8H9O
+
 121.06479 - 7.15 
 106.04105 C7H6O
●+
 106.04186 - 7.64 
 91.05458 C7H7
+
 91.05423 - 3.92 
 77.03932 C6H5
+
 77.03858 - 9.78 
PM: [M + H]
+
 ion; BP: base peak. 
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